Sirnaomics Inc

Precigen, Inc is a dedicated discovery and clinical stage biopharmaceutical company based in Germantown, MD. Specializing in gene and cell therapies, Precigen focuses on immuno-oncology, autoimmune disorders, and infectious diseases, utilizing precision technology to target urgent and intractable medical conditions. Operating as an innovation engine, Precigen progresses a pipeline of unique therapies towards clinical proof of concept and commercialization. With a disciplined design approach and advanced bioengineering technologies, the company aims to deliver potent, on-target gene and cellular therapies with improved safety and efficacy in the fight against cancer. Generated from the website

CosmosID, based in Germantown, MD, specializes in clinical microbiomics and has recently merged with DNASense and MS-Omics to form Cmbio, enhancing their metagenomic services. With over 12 years of experience, they offer a range of sequencing options including amplicon, shotgun, and bacterial isolate sequencing, supported by an industry-leading bioinformatics pipeline. The company is recognized for its exceptional customer service and has aided numerous organizations in scientific research and clinical diagnostics, helping to analyze microbial communities with high precision. CosmosID's robust data-driven solutions and user-friendly software facilitate comprehensive analyses, empowering clients across various sectors to effectively navigate the complexities of the microbiome. Generated from the website

Orgenesis Inc, based in Germantown, MD, is a pioneering company dedicated to unlocking the full potential of cell and gene therapies (CGTs) in an affordable and accessible format. Their innovative POCare Platform offers a pathway to lower costs and standardized CGTs, aiming to bring advanced therapies to patients globally. With a focus on personalized CGTs, Orgenesis is committed to addressing the world's most challenging diseases. Through collaborations with biotech industry leaders, research institutes, and hospitals, they are revolutionizing drug development and scale-up, making advanced therapies more accessible to those in need.Generated from the website